Follow Us
© 2026 Arizent. All rights reserved.
While GLP‑1s have dominated budget conversations and boardroom anxiety, cancer costs are accelerating quietly — and far faster. Cancer has always been expensive, but now it’s one of the most volatile, complex and quickly accelerating areas of employer risk.
Yet many employers simply assume their cancer benefits are “covered.” They offer something — a navigation app, a second‑opinion hotline, a point solution — and believe they’ve built a strategy.
Alex Burggren serves as VP, consultant relations leader at AccessHope, where he focuses on strengthening relationships with the benefits consultancy community and advancing strategic engagement … Read full bio
For reprint and licensing requests for this article, click here.
When providers rush to high-cost procedures, plan sponsors are left subsidizing a bypass of the underlying metabolic issues that most determine pregnancy success.
Despite not being a mandate, the passing of the bill could make a big difference in leaders’ approach.
As healthcare costs climb, more large employers are contracting directly with hospitals and health systems to work out prices, improve quality and steer care.
Asking difficult questions, pushing for transparency, and challenging how prices are set have helped a healthcare provider offer better coverage to its employees.
With health benefit costs expected to rise 8.2% in 2027, employers are looking for ways to control spending without simply shifting more costs to workers.
